Ototoxic drugs are drugs that have an adverse effect on the acoustic nerve or the organs of hearing or balance.
All these drugs are taken as a course of treatment ie prescribed by a doctor as a specified dose to be taken over a number of days (or perhaps weeks).
The RMA has specified the following list of ototoxic drugs as being capable of causing tinnitus or sensorineural hearing loss:
Type | Title | PDF Format | Word Format |
---|---|---|---|
Medical Report | Treatment with Ototoxic Drugs | MR9074.pdf [1] | MR9074.docx [2] |
13658 there is some evidence that treatment with an ototoxic drug may be a factor in the development or worsening of the condition under consideration.
13099 the veteran has undergone a course of treatment with an ototoxic drug from the list specified in the Statements of Principles within the year immediately before the clinical onset or worsening of the condition under consideration.
13101 the veteran underwent a course of treatment with an ototoxic drug from the list specified in the Statements of Principles within the year immediately before the clinical onset or worsening of the condition under consideration for an illness or injury which is identifiable.
13102 the veteran has established the causal connection between the treatment with an ototoxic drug and VEA service for the condition under consideration.
13100 for the identified illness or injury, the veteran underwent a course of treatment with an ototoxic drug from the list specified in the Statements of Principles within the year immediately before the clinical onset of the condition under consideration.
13103 the veteran has established the causal connection between the treatment with an ototoxic drug and VEA service for the clinical onset of the condition under consideration.
30433 the veteran has established the causal connection between the treatment with an ototoxic drug and operational service for the clinical onset of the condition under consideration.
or
30434 the veteran has established the causal connection between the treatment with an ototoxic drug and eligible service for the clinical onset of the condition under consideration.
or
7334 the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.
7335 the condition under consideration permanently worsened.
30432 for the identified illness or injury, the veteran underwent a course of treatment with an ototoxic drug from the list specified in the Statements of Principles within the year immediately before the clinical worsening of the condition under consideration.
13104 the veteran has established the causal connection between the treatment with an ototoxic drug and VEA service for the clinical worsening of the condition under consideration.
30435 the veteran has established the causal connection between the treatment with an ototoxic drug and operational service for the clinical worsening of the condition under consideration.
or
30436 the veteran has established the causal connection between the treatment with an ototoxic drug and eligible service for the clinical worsening of the condition under consideration.
13105 the identified illness or injury, for which the treatment with an ototoxic drug was undergone, is causally related to operational service.
13106 the identified illness or injury, for which the treatment with an ototoxic drug was undergone, is causally related to eligible service.
13105 the identified illness or injury, for which the treatment with an ototoxic drug was undergone, is causally related to operational service.
30437 the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the treatment with an ototoxic drug was undergone, is causally related.
13106 the identified illness or injury, for which the treatment with an ototoxic drug was undergone, is causally related to eligible service.
30438 the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the treatment with an ototoxic drug was undergone, is causally related.
Links
[1] https://clik.dva.gov.au/system/files/media/MR9074.pdf
[2] https://clik.dva.gov.au/system/files/media/MR9074.docx